D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• The SARS-CoV-2 D614G mutation rapidly became globally dominant due to increased infectivity.
• Concerns existed that this mutation might enable immune escape, potentially reducing vaccine efficacy.

Purpose of the Study:

• To investigate whether the D614G mutation in the SARS-CoV-2 spike protein affects neutralization sensitivity.
• To assess the impact of D614G on vaccine efficacy by evaluating antibody neutralization escape.

Main Methods:

• Pseudoviruses expressing either D614 or G614 spike proteins were used.
• Neutralization assays were performed using sera from immunized mice, nonhuman primates, and humans.
• Receptor-binding domain (RBD) monoclonal antibodies and convalescent sera were also tested.
• Negative stain electron microscopy was employed to analyze spike protein conformations.

Main Results:

• Pseudoviruses with the G614 spike were moderately more susceptible to neutralization across all tested sera.
• The G614 pseudovirus showed increased susceptibility to neutralization by RBD monoclonal antibodies and convalescent sera.
• Electron microscopy indicated a higher proportion of the 1-RBD 'up' conformation in G614 spikes, suggesting increased epitope exposure.

Conclusions:

• The D614G mutation does not confer significant neutralization escape from antibodies generated against SARS-CoV-2.
• Increased epitope exposure in the G614 spike may explain its enhanced vulnerability to neutralization.
• The D614G mutation is unlikely to be a barrier to the development and efficacy of current SARS-CoV-2 vaccines.